» Articles » PMID: 15327723

Neuropsychological Sequelae of Obstructive Sleep Apnea-hypopnea Syndrome: a Critical Review

Overview
Specialties Neurology
Psychology
Date 2004 Aug 26
PMID 15327723
Citations 120
Authors
Affiliations
Soon will be listed here.
Abstract

Obstructive sleep apnea-hypopnea syndrome (OSAHS) is a well-recognized clinical sleep disorder that results in chronically fragmented sleep and recurrent hypoxemia. The primary daytime sequelae of the disorder include patient reports of excessive daytime sleepiness, depression, and attention and concentration problems. It has been well established that OSAHS negatively impacts certain aspects of cognitive functioning. The primary goals of this article are to (1) clarify the pattern of cognitive deficits that are specific to OSAHS; (2) identify the specific cognitive domains that improve with treatment; and (3) elucidate the possible mechanisms of cognitive dysfunction in OSAHS. At the conclusion of the paper, we propose a potential neurofunctional theory to account for the etiology of cognitive deficits in OSAHS. Thirty-seven peer-reviewed articles were selected for this review. In general, findings were equivocal for most cognitive domains. Treatment, however, was noted to improve attention/vigilance in most studies and consistently did not improve constructional abilities or psychomotor functioning. The results are discussed in the context of a neurofunctional theory for the effects of OSAHS on the brain.

Citing Articles

Cognitive complaints in patients with untreated obstructive sleep apnea versus patients with neurological and respiratory diseases: prevalence, severity and risk factors.

Vaessen T, Mark R, De Baene W, Gehring K, Overeem S, Sitskoorn M Sleep Breath. 2024; 28(4):1847-1856.

PMID: 38760629 PMC: 11303468. DOI: 10.1007/s11325-024-03056-7.


Sleep disorders affect cognitive function in adults: an overview of systematic reviews and meta-analyses.

Kong J, Zhou L, Li X, Ren Q Sleep Biol Rhythms. 2024; 21(2):133-142.

PMID: 38469285 PMC: 10900040. DOI: 10.1007/s41105-022-00439-9.


Distinct cognitive changes in male patients with obstructive sleep apnoea without co-morbidities.

Gnoni V, Mesquita M, ORegan D, Delogu A, Chakalov I, Antal A Front Sleep. 2024; 2:1097946.

PMID: 38213473 PMC: 7615516. DOI: 10.3389/frsle.2023.1097946.


Effects of CPAP treatment on electroencephalographic activity in patients with obstructive sleep apnea syndrome during deep sleep: Preliminary findings of a cross-sectional study.

Li Y, Li Q, Zou X, Zhong Z, Ouyang Q, Zeng Q Chron Respir Dis. 2023; 20:14799731231215094.

PMID: 37967573 PMC: 10655652. DOI: 10.1177/14799731231215094.


Summary of drug therapy to treat cognitive impairment-induced obstructive sleep apnea.

He D, Chen J, Du X, Xu L Front Cell Neurosci. 2023; 17:1222626.

PMID: 37731463 PMC: 10507626. DOI: 10.3389/fncel.2023.1222626.